Technical indicators are flashing green for a select group of Nifty 200 stocks. Leading the pack are the graphite electrode giants, which have transitioned from “neutral” to “bullish” overnight. The Relative Strength Index (RSI), a key momentum oscillator, has crossed the 50-mark for several companies, signaling that price strength is favoring the buyers.
Here is a look at 5 stocks showing a significant RSI upswing and the catalysts behind their move.
1. HEG Ltd. (RSI: 61.7)
HEG has been the star performer this week, surging over 14% in a single session.
- The Technicals: The stock’s RSI jumped from the mid-40s to 61.7, confirming a decisive momentum shift. It is now trading above all its major exponential moving averages (20, 50, and 200-day EMAs).
- The Trigger: A global pricing reset. US-based peer GrafTech International announced a price hike of $600–$1,200 per tonne, signaling the end of a multi-year pricing slump in the graphite electrode industry.
2. Graphite India (RSI: 51.6)
Following closely behind its peer, Graphite India has also reclaimed key technical levels.
- The Technicals: Its RSI crossed the 50-mark threshold, moving from 41.5 to 51.6. While it faces some resistance near its 50-day SMA (₹645), the “buy” signals from moving averages are piling up.
- The Trigger: As a major global exporter, Graphite India stands to benefit directly from improving realizations in the Electric Arc Furnace (EAF) steelmaking segment.
3. Oracle Financial Services Software (OFSS) (RSI: 55.5)
The IT sector is showing pockets of resilience, and OFSS is a prime example of a momentum recovery.
- The Technicals: The stock’s RSI climbed from 45.8 to 55.5. This “trending up” signal suggests that the stock is exiting a consolidation phase and entering a potential leg of an uptrend.
- Current Price: Trading near the ₹6,947 level, looking to challenge previous swing highs.
4. Anthem Biosciences (RSI: 58.9)
The pharmaceutical and specialty chemicals space is seeing renewed interest, with Anthem Biosciences leading the momentum charts.
- The Technicals: One of the sharpest RSI moves in the Nifty 200, jumping from 46.6 to nearly 59. An RSI above 50 that is sloping upward is a classic “Buy” signal for momentum traders.
- Current Price: Maintaining strength around ₹681.
5. Onesource Specialty Pharma (RSI: 54.5)
Rounding out the list is Onesource Specialty Pharma, which has shown a steady accumulation pattern.
- The Technicals: The RSI surged from a bearish 41.7 to a bullish 54.5. This indicates that the selling pressure has been fully absorbed, and fresh long positions are being built.
- Current Price: Stability around the ₹1,447 mark.
What does an RSI Upswing mean for you?
The Relative Strength Index (RSI) measures the speed and change of price movements on a scale of 0 to 100.
- Below 30: Oversold (Potential for a bounce).
- Above 70: Overbought (Potential for a cooling-off period).
- Crossing 50 from below: This is the “Bullish Upswing” zone. It indicates that the average gains are beginning to outpace the average losses, often marking the start of a sustained rally.
Summary Table: Momentum at a Glance
| Stock Name | Current RSI | Previous RSI | Status |
| HEG Ltd | 61.7 | 46.5 | Strong Momentum |
| Anthem Biosciences | 58.9 | 46.6 | Bullish Trend |
| OFSS | 55.5 | 45.8 | Trend Reversal |
| Onesource Pharma | 54.5 | 41.7 | Accumulation Zone |
| Graphite India | 51.6 | 41.5 | Breakout Watch |
Conclusion
While the RSI upswing is a powerful tool for identifying entry points, it works best when combined with volume and fundamental triggers—like the price hikes we are seeing in the graphite sector. Investors should watch if these stocks can sustain their RSI levels above 50 in the coming sessions to confirm the trend.
How useful was this post?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
Parvati Rai is the Vice President of the Research team at Equentis. She has over 15 years of equity-research and strategy-consulting experience. A specialist in deep-dive valuations, financial modelling, and forecasting, she has built research desks from the ground up, by steering buy-side, sell-side, and independent coverage across sectors. When she isn’t fine-tuning models, Parvati unwinds on nature treks and mentors aspiring analysts.
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai
- Parvati Rai



